Search Results - "WOJDYLA, Daniel M"

Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups by Hong, Chuan, Pencina, Michael J, Wojdyla, Daniel M, Hall, Jennifer L, Judd, Suzanne E, Cary, Michael, Engelhard, Matthew M, Berchuck, Samuel, Xian, Ying, D'Agostino, Sr, Ralph, Howard, George, Kissela, Brett, Henao, Ricardo

“…Stroke is the fifth-highest cause of death in the US and a leading cause of serious long-term disability with particularly high risk in Black individuals…”
Get full text

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin by Hylek, Elaine M., MD, MPH, Held, Claes, MD, PhD, Alexander, John H., MD, MHS, Lopes, Renato D., MD, PhD, De Caterina, Raffaele, MD, PhD, Wojdyla, Daniel M., MS, Huber, Kurt, MD, Jansky, Petr, MD, Steg, Philippe Gabriel, MD, Hanna, Michael, MD, Thomas, Laine, PhD, Wallentin, Lars, MD, PhD, Granger, Christopher B., MD

“…Objectives This study sought to characterize major bleeding on the basis of the components of the major bleeding definition, to explore major bleeding by…”
Get full text

Factors Associated With Major Bleeding Events by Goodman, Shaun G., MD, MSc, Wojdyla, Daniel M., MS, Piccini, Jonathan P., MD, White, Harvey D., MB, ChB, DSc, Paolini, John F., MD, PhD, Nessel, Christopher C., MD, Berkowitz, Scott D., MD, Mahaffey, Kenneth W., MD, Patel, Manesh R., MD, Sherwood, Matthew W., MD, Becker, Richard C., MD, Halperin, Jonathan L., MD, Hacke, Werner, MD, Singer, Daniel E., MD, Hankey, Graeme J., MD, Breithardt, Gunter, MD, Fox, Keith A.A., MB, ChB, Califf, Robert M., MD

“…Objectives This study sought to report additional safety results from the ROCKET AF (Rivaroxaban Once-daily oral Direct Factor Xa Inhibition Compared with…”
Get full text

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial by Easton, J Donald, Dr, Lopes, Renato D, MD, Bahit, M Cecilia, MD, Wojdyla, Daniel M, MS, Granger, Christopher B, MD, Wallentin, Lars, MD, Alings, Marco, MD, Goto, Shinya, MD, Lewis, Basil S, MD, Rosenqvist, Mårten, MD, Hanna, Michael, MD, Mohan, Puneet, MD, Alexander, John H, MD, Diener, Hans-Christoph, MD

“…Summary Background In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by apixaban compared with warfarin in patients with atrial…”
Get full text

Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial by Goto, Shinya, MD, PhD, Zhu, Jun, MD, Liu, Lisheng, MD, Oh, Byung-Hee, MD, PhD, Wojdyla, Daniel M., MS, Aylward, Philip, MD, Bahit, M. Cecilia, MD, Gersh, Bernard J., MD, Hanna, Michael, MD, Horowitz, John, MD, Lopes, Renato D., MD, PhD, Wallentin, Lars, MD, PhD, Xavier, Denis, MD, Alexander, John H., MD, MHS

“…Background The perceived risk of serious bleeding is an obstacle to the use of oral anticoagulation in East Asia. The efficacy and safety of apixaban in East…”
Get full text

The association between triglycerides and incident cardiovascular disease: What is “optimal”? by Aberra, Tsion, Peterson, Eric D., Pagidipati, Neha J., Mulder, Hillary, Wojdyla, Daniel M., Philip, Sephy, Granowitz, Craig, Navar, Ann Marie

“…Elevated triglycerides (TGs) are associated with increased risk of cardiovascular disease (CVD), but the best way to both measure TGs and assess TG-related…”
Get full text

Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial by Mahaffey, Kenneth W., MD, Held, Claes, MD, PhD, Wojdyla, Daniel M., MS, James, Stefan K., MD, PhD, Katus, Hugo A., MD, Husted, Steen, MD, DSc, Steg, Philippe Gabriel, MD, Cannon, Christopher P., MD, Becker, Richard C., MD, Storey, Robert F., MD, DM, Khurmi, Nardev S., MD, Nicolau, José C., MD, PhD, Yu, Cheuk-Man, MD, Ardissino, Diego, MD, Budaj, Andrzej, MD, PhD, Morais, Joao, MD, Montgomery, Debra, Himmelmann, Anders, MD, PhD, Harrington, Robert A., MD, Wallentin, Lars, MD, PhD

“…Objectives This study sought to report the treatment effect of ticagrelor on myocardial infarction (MI) and the strategy for and impact of event adjudication…”
Get full text

Hyponatremia and Long-Term Outcomes in Chronic Heart Failure—An Observational Study From the Duke Databank for Cardiovascular Diseases by Bettari, Luca, MD, Fiuzat, Mona, PharmD, Shaw, Linda K., MS, Wojdyla, Daniel M., MS, Metra, Marco, MD, Felker, G. Michael, MD, O’Connor, Christopher M., MD

“…Abstract Background Hyponatremia is a well known predictor of short-term outcomes in heart failure (HF); however, its impact on long-term survival in HF…”
Get full text

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial by Fudim, Marat, Wojdyla, Daniel M, Alexander, John H, Goodman, Shaun G, Mehran, Roxana, Windecker, Stephan, Aronson, Ronald, Vinereanu, Dragos, Halvorsen, Sigrun, Bahit, M Cecilia, Granger, Christopher B, Lopes, Renato D

Get full text

Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity by Krychtiuk, Konstantin A., Lopes, Renato D., Wojdyla, Daniel M., Goodman, Shaun G., Aronson, Ronald, Windecker, Stephan, Mehran, Roxana, Granger, Christopher B., Alexander, John H., Alexander, Karen P.

“…Patients with atrial fibrillation (AF) after an acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI) with multiple…”
Get full text

Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease by Posenau, J. Trevor, MD, Wojdyla, Daniel M., MS, Shaw, Linda K., MS, Alexander, Karen P., MD, Ohman, E. Magnus, MD, Patel, Manesh R., MD, Smith, Peter K., MD, Rao, Sunil V., MD

“…Background Balancing risks and benefits of revascularization in elderly patients with multivessel coronary artery disease (CAD) is challenging. The appropriate…”
Get full text

Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes) by Kunadian, Vijay, MBBS, MD, James, Stefan K., MD, PhD, Wojdyla, Daniel M., MS, Zorkun, Cafer, MD, PhD, Wu, Jinhui, MD, Storey, Robert F., MD, DM, Steg, Ph. Gabriel, MD, Katus, Hugo, MD, Emanuelsson, Hakan, MD, PhD, Horrow, Jay, MD, MS, Maya, Juan, MD, Wallentin, Lars, MD, PhD, Harrington, Robert A., MD, Gibson, C. Michael, MS, MD

“…Objectives The PLATO (Platelet Inhibition and Patient Outcomes) angiographic substudy sought to compare the efficacy of ticagrelor versus clopidogrel with…”
Get full text

Characteristics and Outcomes of Patients With Heart Failure and Discordant Findings by Right-Sided Heart Catheterization and Cardiopulmonary Exercise Testing by Patel, Chetan B., MD, DeVore, Adam D., MD, Felker, G. Michael, MD, MHS, Wojdyla, Daniel M., MS, Hernandez, Adrian F., MD, MHS, Milano, Carmelo A., MD, O'Connor, Christopher M., MD, Rogers, Joseph G., MD

“…There are limited data integrating findings on right-sided cardiac catheterization and cardiopulmonary exercise testing in ambulatory patients with heart…”
Get full text

Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial by Welsh, Robert C., Dehghani, Payam, Lopes, Renato, Wojdyla, Daniel M, Aronson, Ronald, Granger, Christopher B, Windecker, Stephan, Vora, Amit N, Vinereanu, Dragos, Halvorsen, Sigrun, Parkhomenko, Alexander, Mehran, Roxana, Alexander, John H, Goodman, Shaun

“…ObjectiveManaging antithrombotic therapy in patients with atrial fibrillation (AF) and an acute coronary syndrome (ACS) and/or percutaneous coronary…”
Get full text

Propensity score weighting for causal subgroup analysis by Yang, Siyun, Lorenzi, Elizabeth, Papadogeorgou, Georgia, Wojdyla, Daniel M., Li, Fan, Thomas, Laine E.

“…A common goal in comparative effectiveness research is to estimate treatment effects on prespecified subpopulations of patients. Though widely used in medical…”
Get full text

Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial by Lopes, Renato D., Leonardi, Sergio, Wojdyla, Daniel M., Vora, Amit N., Thomas, Laine, Storey, Robert F., Vinereanu, Dragos, Granger, Christopher B., Goodman, Shaun G., Aronson, Ronald, Windecker, Stephan, Thiele, Holger, Valgimigli, Marco, Mehran, Roxana, Alexander, John H.

Get full text

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease by Stanifer, John W., Pokorney, Sean D., Chertow, Glenn M., Hohnloser, Stefan H., Wojdyla, Daniel M., Garonzik, Samira, Byon, Wonkyung, Hijazi, Ziad, Lopes, Renato D., Alexander, John H., Wallentin, Lars, Granger, Christopher B.

“…BACKGROUND:Compared with the general population, patients with advanced chronic kidney disease have a >10-fold higher burden of atrial fibrillation. Limited…”
Get full text

Comparison of Safety of Sotalol Versus Amiodarone in Patients With Atrial Fibrillation and Coronary Artery Disease by Piccini, Jonathan P., MD, MHS, Al-Khatib, Sana M., MD, MHS, Wojdyla, Daniel M., MS, Shaw, Linda K., MS, Horton, John R., MS, Lokhnygina, Yuliya, PhD, Anstrom, Kevin J., PhD, DeWald, Tracy, PharmD, MHS, Allen-LaPointe, Nancy, PharmD, Steinberg, Benjamin A., MD, MHS, Thomas, Kevin, MD, Daubert, James P., MD, Peterson, Eric D., MD, MPH

“…Sotalol is a commonly prescribed antiarrhythmic drug (AAD) used for maintaining sinus rhythm in patients with atrial fibrillation (AF). Although randomized…”
Get full text

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes by HYLEK, Elaine M, HELD, Claes, THOMAS, Laine, WALLENTIN, Lars, GRANGER, Christopher B, ALEXANDER, John H, LOPES, Renato D, DE CATERINA, Raffaele, WOJDYLA, Daniel M, HUBER, Kurt, JANSKY, Petr, STEG, Philippe Gabriel, HANNA, Michael

“…This study sought to characterize major bleeding on the basis of the components of the major bleeding definition, to explore major bleeding by location, to…”
Get full text

Trans-Balance: Reducing demographic disparity for prediction models in the presence of class imbalance by Hong, Chuan, Liu, Molei, Wojdyla, Daniel M., Hickey, Jimmy, Pencina, Michael, Henao, Ricardo

“…Risk prediction, including early disease detection, prevention, and intervention, is essential to precision medicine. However, systematic bias in risk…”
Get full text